Abstract:Abstract Atopic dermatitis (AD) is a common, relapsing–remitting inflammatory skin disease that is associated with other disorders such as food allergy, allergic asthma and rhinitis, leading to increased rates of morbidity and mortality. The discovery of CD1a involvement in AD pathogenesis through the presentation of permissive neolipid antigens generated by house dust mite phospholipase A2 (PLA2) enhanced our understanding of the complex network of T-cell targets that contribute to disease development. As well as defining agonist lipids, it is now known that very long-chain sphingomyelins can act as natural lipid antagonists of CD1a–T-cell receptor (TCR) engagement. We sought to determine whether bacterial sphingomyelinases (SMases) could also activate CD1a-reactive T cells and help explain the known bacterial infection-associated manifestations of AD. An isoelectric focusing system was used to evaluate the hydrolytic capacity of bacterial SMases on very long-chain CD1a-preferred sphingomyelins. Additionally, this approach permitted examination of the impact of cobalt and nickel ions on bacterial SMase activity. Furthermore, using primary human T-cell clones and TCR transfer with CRISPR Homology Directed Repair, we evaluated SMase-reactive CD1a-dependent T-cell responses. Moreover, we examined both lesional and nonlesional skin from patients with AD, patients with psoriasis and healthy controls using RNA-Seq. Bacterial SMases were able to digest CD1a-selected sphingomyelins, and the enzymatic activity was potentiated by the presence of divalent metal ions, which are known contact dermatitis allergens. Furthermore, bacterial SMase-reactive CD1a-dependent T-cell responses were identified through markedly increased detection of AD-associated inflammatory cytokines and elevated activation marker expression. Consistency of responses between the primary T-cell clones and HDR T cells confirmed that these responses were indeed TCR specific. Skin transcriptomic changes included altered lipid processing pathways, in particular, mammalian SMase and PLA2-mediated pathways, activated in lesional tissue. We showed that bacterial SMases can effectively degrade very long-chain antagonist sphingomyelins and potentiate CD1a-reactive T-cell responses. In addition, our bioinformatics analysis revealed enhanced expression of mammalian SMases in lesional AD and psoriasis, suggesting potential broad involvement of this enzyme class in skin inflammation. This study extends our understanding of the role of lipid-metabolizing enzymes to CD1a-dependent T-cell activation in AD pathology, as well as defining a hitherto unknown pathway of contact dermatitis. The mechanisms provide insights towards novel targets for therapeutic intervention. The principal investigator has received relevant research collaboration support from UCB and Janssen. The principal investigator and some members of the group are on patents filed on CD1a.

S. epidermidis Rescues Allergic Contact Dermatitis in Sphingosine 1-Phosphate Receptor 2-Deficient Skin

Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections.

Staphylococcus epidermidis augments human β-defensin-3 synthesis through the transforming growth factor alpha-epidermal growth factor receptor cascade

Increased Susceptibility of S1PR3-Deficient Mice to Escherichia Coli Sepsis is Associated with an Impaired Bactericidal Activity in Macrophage

Multilineage-differentiating stress-enduring cells alleviate atopic dermatitis-associated behaviors in mice

Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides

Sphingosine 1-Phosphate Receptor-3 Contributes to Host Defense Against Polymicrobial Sepsis Via Modulating Macrophage Chemotaxis (CAM4P.161)

Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin

Sphingosine 1-phosphate receptor 2 in keratinocytes plays a key role in reducing inflammation in psoriasis

Overexpression of the β-Subunit of Acid Ceramidase in the Epidermis of Mice Provokes Atopic Dermatitis-like Skin Symptoms

CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity

Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model

Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases

CD15 The role of lipid-metabolizing enzymes in CD1a-associated cutaneous inflammation

Staphylococcus aureus second immunoglobulin-binding protein drives atopic dermatitis via IL-33

Loss of Sirtuin 1 (SIRT1) Disrupts Skin Barrier Integrity and Sensitizes Mice to Epicutaneous Allergen Challenge

Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.

Staphylococcus Aureus Causes Aberrant Epidermal Lipid Composition and Skin Barrier Dysfunction.

Mast Cells Limit the Exacerbation of Chronic Allergic Contact Dermatitis in Response to Repeated Allergen Exposure

Selective Antimicrobial Action Is Provided by Phenol-Soluble Modulins Derived from Staphylococcus epidermidis, a Normal Resident of the Skin

Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis